Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David W. Golding currently holds 116,525 shares of BioScrip, Inc. (BIOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David W. Golding has been a net buyer of BIOS stock. They have purchased $129.6K and sold $0 worth of shares.
David W. Golding's most recent insider trade was on Aug 21, 2025, when they purchased 1,000 shares at $27.63 per share.
David W. Golding serves as Executive at BioScrip, Inc. (BIOS). They have executed 17 insider transactions totaling $129.6K over their tenure at the company.
David W. Golding holds the position of Executive at BioScrip, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David W. Golding has shown a buying trading pattern, with $129.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David W. Golding was on May 19, 2015, when they purchased $40.2K worth of BIOS shares. This transaction involved 10,000 shares at $4.02 per share.
David W. Golding currently owns 116,525 shares of BioScrip, Inc. (BIOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David W. Golding's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David W. Golding has 17 Form 4 filings on record as an insider at BioScrip, Inc..
Set alerts for David W. Golding and 40,000+ other insiders.